Dr. Reddy's Laboratories Limited — Others, 05-12-2024: Action(s) initiated or orders passed

Dr. Reddy’s Laboratories' step-down wholly-owned subsidiary, Dr. Reddy’s Laboratories Kazakhstan LLP, has received a penalty order of KZT 17,597,212 (approximately INR 2.87 crore) from the Department of State Revenue in Almaty for disallowing certain expense claims for the calendar year 2021. Despite this penalty, the company assesses that there will be no material impact on its financials or operations. This development may pose a minor risk, but it does not significantly alter the outlook for the company's overall performance, suggesting a stable environment for investors.